Pawlotsky, J.M.

patient treatment genotype response hepatitis hepatitis c model study therapy steatosi virus t-cell decline kinetic ribavirin baseline hcv rna liver hepatitis c virus outcome hcv-rna phase treatment outcome group score stage plasma value signi level infection allele il 28b analysis interferon guci score index ishak hepatology cirrhosis brosi rs 12979860 -10 hcv-speci result table university 8 model ficant hcv genotype 1 prediction figure association fi rst month frequency hla-a fibrosis fi brosis genotype 1 peptide phase decline peginterferon fi rst phase biopsy ip -10 virological response rs 8099917 hepatitis c patients sample journal t-cell lines polymorphism il 28b polymorphisms t-cell response effect hla-a 2 decay virological trial expansion